Hyperhomocysteinaemia is an independent risk factor for peripheral arterial disease in a Chinese Han population
Hyperhomocysteineamia (HHcy) has long been suggested as a risk factor for atherosclerosis. However, the association between HHcy and peripheral arterial disease (PAD) is still controversial. There is a lack of research on this topic in the Chinese population. This study aims to provide further resul...
Saved in:
Published in | Atherosclerosis Vol. 263; pp. 205 - 210 |
---|---|
Main Authors | , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Ireland
Elsevier B.V
01.08.2017
|
Subjects | |
Online Access | Get full text |
ISSN | 0021-9150 1879-1484 1879-1484 |
DOI | 10.1016/j.atherosclerosis.2017.05.006 |
Cover
Abstract | Hyperhomocysteineamia (HHcy) has long been suggested as a risk factor for atherosclerosis. However, the association between HHcy and peripheral arterial disease (PAD) is still controversial. There is a lack of research on this topic in the Chinese population. This study aims to provide further results.
240 PAD patients and 240 control subjects were evaluated for both serum total homocysteine levels and ankle brachial indexes (ABIs). Multivariable logistic regression models were used to estimate the association between HHcy and the risk of developing PAD. Interaction and stratified analyses were conducted according to age, sex, smoking status, drinking status, and histories of chronic disease.
The multivariate logistic regression analyses revealed that the risk of PAD was significantly associated with serum homocysteine levels. The interaction analysis showed no interactive role in the association between HHcy and PAD, indicating that homocysteine was associated with PAD independently of classical vascular risk factors.
In conclusion, HHcy is an independent risk factor for PAD in the Chinese Han population. A prospective and randomized clinical trial of homocysteine lowering therapy in the Chinese population is needed to assess the causal nature of the relationship.
•Participants with hyperhomocysteinaemia (HHcy) suffer a higher risk of peripheral arterial disease (PAD).•HHcy is an independent risk factor for PAD in a Chinese Han population.•This is the first case-control study to investigate the relationship between HHcy and PAD in Chinese mainland. |
---|---|
AbstractList | Hyperhomocysteineamia (HHcy) has long been suggested as a risk factor for atherosclerosis. However, the association between HHcy and peripheral arterial disease (PAD) is still controversial. There is a lack of research on this topic in the Chinese population. This study aims to provide further results.
240 PAD patients and 240 control subjects were evaluated for both serum total homocysteine levels and ankle brachial indexes (ABIs). Multivariable logistic regression models were used to estimate the association between HHcy and the risk of developing PAD. Interaction and stratified analyses were conducted according to age, sex, smoking status, drinking status, and histories of chronic disease.
The multivariate logistic regression analyses revealed that the risk of PAD was significantly associated with serum homocysteine levels. The interaction analysis showed no interactive role in the association between HHcy and PAD, indicating that homocysteine was associated with PAD independently of classical vascular risk factors.
In conclusion, HHcy is an independent risk factor for PAD in the Chinese Han population. A prospective and randomized clinical trial of homocysteine lowering therapy in the Chinese population is needed to assess the causal nature of the relationship. Hyperhomocysteineamia (HHcy) has long been suggested as a risk factor for atherosclerosis. However, the association between HHcy and peripheral arterial disease (PAD) is still controversial. There is a lack of research on this topic in the Chinese population. This study aims to provide further results. 240 PAD patients and 240 control subjects were evaluated for both serum total homocysteine levels and ankle brachial indexes (ABIs). Multivariable logistic regression models were used to estimate the association between HHcy and the risk of developing PAD. Interaction and stratified analyses were conducted according to age, sex, smoking status, drinking status, and histories of chronic disease. The multivariate logistic regression analyses revealed that the risk of PAD was significantly associated with serum homocysteine levels. The interaction analysis showed no interactive role in the association between HHcy and PAD, indicating that homocysteine was associated with PAD independently of classical vascular risk factors. In conclusion, HHcy is an independent risk factor for PAD in the Chinese Han population. A prospective and randomized clinical trial of homocysteine lowering therapy in the Chinese population is needed to assess the causal nature of the relationship. •Participants with hyperhomocysteinaemia (HHcy) suffer a higher risk of peripheral arterial disease (PAD).•HHcy is an independent risk factor for PAD in a Chinese Han population.•This is the first case-control study to investigate the relationship between HHcy and PAD in Chinese mainland. Abstract Background and aims Hyperhomocysteineamia (HHcy) has long been suggested as a risk factor for atherosclerosis. However, the association between HHcy and peripheral arterial disease (PAD) is still controversial. There is a lack of research on this topic in the Chinese population. This study aims to provide further results. Methods 240 PAD patients and 240 control subjects were evaluated for both serum total homocysteine levels and ankle brachial indexes (ABIs). Multivariable logistic regression models were used to estimate the association between HHcy and the risk of developing PAD. Interaction and stratified analyses were conducted according to age, sex, smoking status, drinking status, and histories of chronic disease. Results The multivariate logistic analyses revealed that the risk of PAD was significantly associated with serum homocysteine levels. The interaction analysis showed no interactive role in the association between HHcy and PAD, indicating that homocysteine was associated with PAD independent of classical vascular risk factors. Conclusions In conclusion, HHcy is an independent risk factor for PAD in the Chinese Han population. A prospective and randomized clinical trial of homocysteine lowering therapy in the Chinese population is needed to assess the causal nature of the relationship. Hyperhomocysteineamia (HHcy) has long been suggested as a risk factor for atherosclerosis. However, the association between HHcy and peripheral arterial disease (PAD) is still controversial. There is a lack of research on this topic in the Chinese population. This study aims to provide further results.BACKGROUND AND AIMSHyperhomocysteineamia (HHcy) has long been suggested as a risk factor for atherosclerosis. However, the association between HHcy and peripheral arterial disease (PAD) is still controversial. There is a lack of research on this topic in the Chinese population. This study aims to provide further results.240 PAD patients and 240 control subjects were evaluated for both serum total homocysteine levels and ankle brachial indexes (ABIs). Multivariable logistic regression models were used to estimate the association between HHcy and the risk of developing PAD. Interaction and stratified analyses were conducted according to age, sex, smoking status, drinking status, and histories of chronic disease.METHODS240 PAD patients and 240 control subjects were evaluated for both serum total homocysteine levels and ankle brachial indexes (ABIs). Multivariable logistic regression models were used to estimate the association between HHcy and the risk of developing PAD. Interaction and stratified analyses were conducted according to age, sex, smoking status, drinking status, and histories of chronic disease.The multivariate logistic regression analyses revealed that the risk of PAD was significantly associated with serum homocysteine levels. The interaction analysis showed no interactive role in the association between HHcy and PAD, indicating that homocysteine was associated with PAD independently of classical vascular risk factors.RESULTSThe multivariate logistic regression analyses revealed that the risk of PAD was significantly associated with serum homocysteine levels. The interaction analysis showed no interactive role in the association between HHcy and PAD, indicating that homocysteine was associated with PAD independently of classical vascular risk factors.In conclusion, HHcy is an independent risk factor for PAD in the Chinese Han population. A prospective and randomized clinical trial of homocysteine lowering therapy in the Chinese population is needed to assess the causal nature of the relationship.CONCLUSIONSIn conclusion, HHcy is an independent risk factor for PAD in the Chinese Han population. A prospective and randomized clinical trial of homocysteine lowering therapy in the Chinese population is needed to assess the causal nature of the relationship. |
Author | Jia, Xin Khalil, Raouf A. Zhang, Hongpeng Liu, Jie Guo, Wei Sun, Guoyi Ma, Xiaohui AL-Nafisee, Daniah Xiong, Jiang Jia, Senhao Li, Yue Li, Haifeng Rong, Dan Lu, Weihang Liu, Xiaoping |
AuthorAffiliation | a Department of Vascular and Endovascular Surgery, Chinese PLA General Hospital, Beijing, China e Department of Vascular and Endovascular Surgery, Shanxian Dongda Hospital, Heze, Shandong, China b Vascular Surgery Research Laboratories, Division of Vascular and Endovascular Surgery, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts c School of Medicine, The Royal College of Surgeons, Dublin, Ireland d Department of Cardiovascular Surgery, Chinese PLA Air Force General Hospital, Beijing, China |
AuthorAffiliation_xml | – name: b Vascular Surgery Research Laboratories, Division of Vascular and Endovascular Surgery, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts – name: a Department of Vascular and Endovascular Surgery, Chinese PLA General Hospital, Beijing, China – name: e Department of Vascular and Endovascular Surgery, Shanxian Dongda Hospital, Heze, Shandong, China – name: c School of Medicine, The Royal College of Surgeons, Dublin, Ireland – name: d Department of Cardiovascular Surgery, Chinese PLA Air Force General Hospital, Beijing, China |
Author_xml | – sequence: 1 givenname: Dan surname: Rong fullname: Rong, Dan organization: Department of Vascular and Endovascular Surgery, Chinese PLA General Hospital, Beijing, China – sequence: 2 givenname: Jie surname: Liu fullname: Liu, Jie organization: Department of Vascular and Endovascular Surgery, Chinese PLA General Hospital, Beijing, China – sequence: 3 givenname: Xin surname: Jia fullname: Jia, Xin organization: Department of Vascular and Endovascular Surgery, Chinese PLA General Hospital, Beijing, China – sequence: 4 givenname: Daniah surname: AL-Nafisee fullname: AL-Nafisee, Daniah organization: School of Medicine, The Royal College of Surgeons, Dublin, Ireland – sequence: 5 givenname: Senhao surname: Jia fullname: Jia, Senhao organization: Department of Vascular and Endovascular Surgery, Chinese PLA General Hospital, Beijing, China – sequence: 6 givenname: Guoyi surname: Sun fullname: Sun, Guoyi organization: Department of Vascular and Endovascular Surgery, Chinese PLA General Hospital, Beijing, China – sequence: 7 givenname: Yue surname: Li fullname: Li, Yue organization: Department of Cardiovascular Surgery, Chinese PLA Air Force General Hospital, Beijing, China – sequence: 8 givenname: Weihang surname: Lu fullname: Lu, Weihang organization: Department of Vascular and Endovascular Surgery, Chinese PLA General Hospital, Beijing, China – sequence: 9 givenname: Haifeng surname: Li fullname: Li, Haifeng organization: Department of Vascular and Endovascular Surgery, Shanxian Dongda Hospital, Heze, Shandong, China – sequence: 10 givenname: Hongpeng surname: Zhang fullname: Zhang, Hongpeng organization: Department of Vascular and Endovascular Surgery, Chinese PLA General Hospital, Beijing, China – sequence: 11 givenname: Xiaohui surname: Ma fullname: Ma, Xiaohui organization: Department of Vascular and Endovascular Surgery, Chinese PLA General Hospital, Beijing, China – sequence: 12 givenname: Jiang surname: Xiong fullname: Xiong, Jiang organization: Department of Vascular and Endovascular Surgery, Chinese PLA General Hospital, Beijing, China – sequence: 13 givenname: Xiaoping surname: Liu fullname: Liu, Xiaoping organization: Department of Vascular and Endovascular Surgery, Chinese PLA General Hospital, Beijing, China – sequence: 14 givenname: Raouf A. surname: Khalil fullname: Khalil, Raouf A. organization: Vascular Surgery Research Laboratories, Division of Vascular and Endovascular Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA – sequence: 15 givenname: Wei surname: Guo fullname: Guo, Wei email: guoweiplagh@sina.com organization: Department of Vascular and Endovascular Surgery, Chinese PLA General Hospital, Beijing, China |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/28651188$$D View this record in MEDLINE/PubMed |
BookMark | eNqVkk1v1DAQhi1URLeFv4ByQeKywU6cxDlQCa1KF6kSB-BsOc6EnW1iBzuptP-eCdsiWAmpHPwlzzwzfl9fsDPnHTD2RvBUcFG-26dm2kHw0fbLjDHNuKhSXqScl8_YSqiqXgup5BlbcZ6JdS0Kfs4uYtxzzmUl1At2nqmyEEKpFfPbwwhh5wdvD3ECdAYGNAnGxLgEXQsj0OSmJGC8SzpjJx-SjgZl4UiNmD4xYaIDbVqMYCJQXmKSzQ4d0GFLoNGPc28m9O4le96ZPsKrh_WSfft4_XWzXd9-vvm0-XC7tqUop3Vl2rqVjbClrGQrlK2aRsqmtrnkEkqojelU3tWNqekuLzkHk3cqgzaXIm9lfsmujtxxbgZoLT2BWtVjwMGEg_YG9d83Dnf6u7_XRVFUpSoI8PYBEPyPGeKkB4wW-t448HPUohaSZFSZotDXf9b6XeRRZQrYHAMsORYDdNri9EsOKo29Flwv3uq9PvFWL95qXmjylijvTyiPhZ6af3PMB9L9HiHoaBGchRYD2Em3Hp9Mujoh2R4dWtPfwQHi3s_Bkbla6Jhprr8s_3D5hqLKuaiLRZDrfwP-o5GfqGP9Cg |
CitedBy_id | crossref_primary_10_1016_j_avsg_2020_11_043 crossref_primary_10_1080_02713683_2021_1894581 crossref_primary_10_1016_j_omtn_2021_10_031 crossref_primary_10_1097_MD_0000000000009801 crossref_primary_10_1186_s40001_022_00870_1 crossref_primary_10_3389_fphys_2018_01000 crossref_primary_10_3892_mmr_2019_10804 crossref_primary_10_1155_2020_4378505 crossref_primary_10_1080_07853890_2025_2457527 crossref_primary_10_1186_s12872_023_03586_0 crossref_primary_10_1016_j_jhin_2018_06_017 crossref_primary_10_1080_15384101_2018_1480207 crossref_primary_10_12677_acm_2024_1441346 crossref_primary_10_1155_2020_4691026 crossref_primary_10_1016_j_amjcard_2024_03_002 crossref_primary_10_2147_DMSO_S309242 crossref_primary_10_1155_2020_6960497 crossref_primary_10_2478_jtim_2021_0035 crossref_primary_10_3389_fcvm_2022_1109445 crossref_primary_10_1016_j_avsg_2019_06_026 crossref_primary_10_2147_DMSO_S267122 crossref_primary_10_1111_jch_14766 crossref_primary_10_1002_ptr_7519 |
Cites_doi | 10.1056/NEJMoa060900 10.1016/j.freeradbiomed.2013.07.041 10.1016/S0140-6736(13)61249-0 10.1016/0735-1097(95)00508-0 10.1017/S0029665108007076 10.1016/S0950-821X(05)80255-5 10.1001/jama.2015.2274 10.1016/j.jclinepi.2006.01.014 10.1016/j.ab.2014.08.013 10.1056/NEJMcp1507631 10.1053/meta.2001.23286 10.1007/s00392-012-0471-z 10.1001/archinternmed.2010.348 10.1016/j.jvs.2008.10.004 10.1001/jama.285.19.2481 10.1016/j.atherosclerosis.2014.04.010 10.1097/00008571-200210000-00003 10.1093/eurheartj/ehu080 10.1016/0021-9150(90)90058-Q 10.1161/CIR.0b013e318276fbcb 10.1016/j.ejvs.2009.05.007 10.1056/NEJM199104253241701 10.1056/NEJM199804093381507 10.1586/17512433.2015.1010516 10.1161/CIRCULATIONAHA.105.608679 10.1161/CIRCULATIONAHA.107.719369 10.1038/srep17966 10.1016/0741-5214(91)90020-U 10.1016/0002-9343(94)90149-X 10.1001/jama.295.2.180 10.1007/s100169900037 10.1093/ije/25.2.282 10.1038/nm0496-386 10.1001/jama.1995.03530130055028 |
ContentType | Journal Article |
Copyright | 2017 Elsevier B.V. Copyright © 2017 Elsevier B.V. All rights reserved. |
Copyright_xml | – notice: 2017 Elsevier B.V. – notice: Copyright © 2017 Elsevier B.V. All rights reserved. |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 5PM |
DOI | 10.1016/j.atherosclerosis.2017.05.006 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1879-1484 |
EndPage | 210 |
ExternalDocumentID | PMC5557685 28651188 10_1016_j_atherosclerosis_2017_05_006 S0021915017301958 1_s2_0_S0021915017301958 |
Genre | Research Support, Non-U.S. Gov't Journal Article Research Support, N.I.H., Extramural |
GrantInformation_xml | – fundername: NHLBI NIH HHS grantid: R21 HL111775 – fundername: NHLBI NIH HHS grantid: R01 HL065998 |
GroupedDBID | --- --K --M .1- .55 .FO .GJ .~1 0R~ 1B1 1P~ 1RT 1~. 1~5 23N 3O- 4.4 457 4G. 53G 5GY 5RE 5VS 7-5 71M 8P~ 9JM AABNK AAEDT AAEDW AAFWJ AAIKJ AAKOC AALRI AAOAW AAQFI AATTM AAXKI AAXUO AAYWO ABBQC ABFNM ABJNI ABLJU ABMAC ABMZM ABOCM ABXDB ACDAQ ACGFS ACIEU ACIUM ACRLP ACVFH ADBBV ADCNI ADEZE AEBSH AEIPS AEKER AENEX AEUPX AEVXI AEXQZ AFFNX AFJKZ AFPUW AFRHN AFTJW AFXIZ AGCQF AGHFR AGUBO AGYEJ AHHHB AIEXJ AIGII AIIUN AIKHN AITUG AJRQY AJUYK AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ ANKPU ANZVX APXCP ASPBG AVWKF AXJTR AZFZN BKOJK BLXMC BNPGV CS3 EBS EFJIC EFKBS EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN G-2 G-Q GBLVA HEB HMK HMO HVGLF HZ~ IHE J1W J5H K-O KOM L7B M27 M41 MO0 N9A O-L O9- OAUVE OA~ OK1 OL0 OZT P-8 P-9 P2P PC. Q38 R2- ROL RPZ SAE SCC SDF SDG SDP SEL SES SEW SPCBC SSH SSZ T5K WUQ X7M Z5R ZGI ZXP ~G- ~KM AACTN AFCTW AFKWA AJOXV AMFUW NCXOZ RIG 0SF AAIAV ABLVK ABYKQ AHPSJ AJBFU EFLBG LCYCR ZA5 AAYXX ACLOT CITATION ~HD AGRNS CGR CUY CVF ECM EIF NPM 7X8 5PM |
ID | FETCH-LOGICAL-c616t-7ad9d4b1c6474d18c7bb44b9c3404e6e9aaf83f9ba98c73600ea3f82ed3413d43 |
IEDL.DBID | .~1 |
ISSN | 0021-9150 1879-1484 |
IngestDate | Tue Sep 30 16:12:12 EDT 2025 Sat Sep 27 20:19:03 EDT 2025 Mon Jul 21 06:00:18 EDT 2025 Thu Apr 24 22:56:01 EDT 2025 Wed Oct 01 05:20:42 EDT 2025 Fri Feb 23 02:49:21 EST 2024 Sun Feb 23 10:19:10 EST 2025 Tue Aug 26 16:36:41 EDT 2025 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Keywords | WHS PLA CAD Peripheral arterial disease ABI Case-control study Hyperhomocysteineamia HDL PAD 5-MTHF LDL HHcy NHS PHS Homocysteine HOPE coronary artery disease people's liberation army Physicians' Health Study Heart Outcomes Prevention Evaluation high-density lipoprotein 5-methyltetrahydrofolate Nurses' Health Study Women's Health Study ankle brachial index low-density lipoprotein |
Language | English |
License | Copyright © 2017 Elsevier B.V. All rights reserved. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c616t-7ad9d4b1c6474d18c7bb44b9c3404e6e9aaf83f9ba98c73600ea3f82ed3413d43 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 These authors contributed equally to this work. |
OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/5557685 |
PMID | 28651188 |
PQID | 1914286828 |
PQPubID | 23479 |
PageCount | 6 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_5557685 proquest_miscellaneous_1914286828 pubmed_primary_28651188 crossref_citationtrail_10_1016_j_atherosclerosis_2017_05_006 crossref_primary_10_1016_j_atherosclerosis_2017_05_006 elsevier_sciencedirect_doi_10_1016_j_atherosclerosis_2017_05_006 elsevier_clinicalkeyesjournals_1_s2_0_S0021915017301958 elsevier_clinicalkey_doi_10_1016_j_atherosclerosis_2017_05_006 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2017-08-01 |
PublicationDateYYYYMMDD | 2017-08-01 |
PublicationDate_xml | – month: 08 year: 2017 text: 2017-08-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | Ireland |
PublicationPlace_xml | – name: Ireland |
PublicationTitle | Atherosclerosis |
PublicationTitleAlternate | Atherosclerosis |
PublicationYear | 2017 |
Publisher | Elsevier B.V |
Publisher_xml | – name: Elsevier B.V |
References | Kumbhani (bib5) 2014; 35 Beutner (bib21) 2012; 101 Brown (bib31) 2014; 467 Kullo, Rooke (bib1) 2016; 374 Boushey (bib13) 1995; 274 Fowkes (bib2) 2013; 382 Bertoia (bib27) 2014; 235 Khandanpour (bib17) 2009; 38 Liu (bib19) 2016; 6 Ridker, Stampfer, Rifai (bib23) 2001; 285 Mayer, Jacobsen, Robinson (bib12) 1996; 27 Welch, Loscalzo (bib9) 1998; 338 Taylor (bib25) 1991; 13 Dierkes (bib28) 2001; 50 Lonn (bib36) 2006; 354 McNulty (bib33) 2008; 67 Brattstrom (bib15) 1990; 81 Goodman (bib30) 2002; 12 McCully (bib32) 2015; 8 Aboyans (bib24) 2006; 113 Donders (bib22) 2006; 59 Bhatt (bib4) 2006; 295 McCully (bib6) 1969; 56 Pradhan (bib26) 2008; 117 Khandanpour (bib34) 2009; 49 Huo (bib35) 2015; 313 Clarke (bib14) 1991; 324 Ueland, Refsum (bib7) 1989; 114 Chauveau (bib10) 1993; 41 Cheng, Ting, Wong (bib18) 1997; 11 Aboyans (bib20) 2012; 126 Savage (bib11) 1994; 96 Stoffers (bib3) 1996; 25 McCully (bib8) 1996; 2 Bergmark (bib16) 1993; 7 Gaikwad (bib29) 2013; 65 Clarke (bib37) 2010; 170 Ridker (10.1016/j.atherosclerosis.2017.05.006_bib23) 2001; 285 Brattstrom (10.1016/j.atherosclerosis.2017.05.006_bib15) 1990; 81 Gaikwad (10.1016/j.atherosclerosis.2017.05.006_bib29) 2013; 65 Kumbhani (10.1016/j.atherosclerosis.2017.05.006_bib5) 2014; 35 Welch (10.1016/j.atherosclerosis.2017.05.006_bib9) 1998; 338 Mayer (10.1016/j.atherosclerosis.2017.05.006_bib12) 1996; 27 Chauveau (10.1016/j.atherosclerosis.2017.05.006_bib10) 1993; 41 Khandanpour (10.1016/j.atherosclerosis.2017.05.006_bib17) 2009; 38 Bhatt (10.1016/j.atherosclerosis.2017.05.006_bib4) 2006; 295 Aboyans (10.1016/j.atherosclerosis.2017.05.006_bib24) 2006; 113 Fowkes (10.1016/j.atherosclerosis.2017.05.006_bib2) 2013; 382 Clarke (10.1016/j.atherosclerosis.2017.05.006_bib14) 1991; 324 Savage (10.1016/j.atherosclerosis.2017.05.006_bib11) 1994; 96 McCully (10.1016/j.atherosclerosis.2017.05.006_bib8) 1996; 2 Bertoia (10.1016/j.atherosclerosis.2017.05.006_bib27) 2014; 235 Dierkes (10.1016/j.atherosclerosis.2017.05.006_bib28) 2001; 50 McNulty (10.1016/j.atherosclerosis.2017.05.006_bib33) 2008; 67 Donders (10.1016/j.atherosclerosis.2017.05.006_bib22) 2006; 59 Clarke (10.1016/j.atherosclerosis.2017.05.006_bib37) 2010; 170 Beutner (10.1016/j.atherosclerosis.2017.05.006_bib21) 2012; 101 Bergmark (10.1016/j.atherosclerosis.2017.05.006_bib16) 1993; 7 Aboyans (10.1016/j.atherosclerosis.2017.05.006_bib20) 2012; 126 Huo (10.1016/j.atherosclerosis.2017.05.006_bib35) 2015; 313 Ueland (10.1016/j.atherosclerosis.2017.05.006_bib7) 1989; 114 Boushey (10.1016/j.atherosclerosis.2017.05.006_bib13) 1995; 274 Pradhan (10.1016/j.atherosclerosis.2017.05.006_bib26) 2008; 117 Lonn (10.1016/j.atherosclerosis.2017.05.006_bib36) 2006; 354 McCully (10.1016/j.atherosclerosis.2017.05.006_bib6) 1969; 56 Goodman (10.1016/j.atherosclerosis.2017.05.006_bib30) 2002; 12 Liu (10.1016/j.atherosclerosis.2017.05.006_bib19) 2016; 6 Kullo (10.1016/j.atherosclerosis.2017.05.006_bib1) 2016; 374 Stoffers (10.1016/j.atherosclerosis.2017.05.006_bib3) 1996; 25 Taylor (10.1016/j.atherosclerosis.2017.05.006_bib25) 1991; 13 McCully (10.1016/j.atherosclerosis.2017.05.006_bib32) 2015; 8 Cheng (10.1016/j.atherosclerosis.2017.05.006_bib18) 1997; 11 Brown (10.1016/j.atherosclerosis.2017.05.006_bib31) 2014; 467 Khandanpour (10.1016/j.atherosclerosis.2017.05.006_bib34) 2009; 49 12360102 - Pharmacogenetics. 2002 Oct;12(7):517-28 8154512 - Am J Med. 1994 Mar;96(3):239-46 16403930 - JAMA. 2006 Jan 11;295(2):180-9 25771069 - JAMA. 2015 Apr 7;313(13):1325-35 8359294 - Eur J Vasc Surg. 1993 Jul;7(4):391-6 25172130 - Anal Biochem. 2014 Dec 15;467:14-21 9140594 - Ann Vasc Surg. 1997 May;11(3):217-23 23159553 - Circulation. 2012 Dec 11;126(24):2890-909 16980149 - J Clin Epidemiol. 2006 Oct;59(10):1087-91 23915883 - Lancet. 2013 Oct 19;382(9901):1329-40 7563456 - JAMA. 1995 Oct 4;274(13):1049-57 23928335 - Free Radic Biol Med. 2013 Dec;65:1447-54 8320950 - Kidney Int Suppl. 1993 Jun;41:S72-7 9535670 - N Engl J Med. 1998 Apr 9;338(15):1042-50 19157768 - J Vasc Surg. 2009 Mar;49(3):711-8 24819748 - Atherosclerosis. 2014 Jul;235(1):94-101 9119553 - Int J Epidemiol. 1996 Apr;25(2):282-90 22584382 - Clin Res Cardiol. 2012 Nov;101(11):875-83 19560951 - Eur J Vasc Endovasc Surg. 2009 Sep;38(3):316-22 11368701 - JAMA. 2001 May 16;285(19):2481-5 26962905 - N Engl J Med. 2016 Mar 3;374(9):861-71 8597939 - Nat Med. 1996 Apr;2(4):386-9 8606260 - J Am Coll Cardiol. 1996 Mar 1;27(3):517-27 2681479 - J Lab Clin Med. 1989 Nov;114(5):473-501 16735675 - Circulation. 2006 Jun 6;113(22):2623-9 20937919 - Arch Intern Med. 2010 Oct 11;170(18):1622-31 18412997 - Proc Nutr Soc. 2008 May;67(2):232-7 24585266 - Eur Heart J. 2014 Nov 1;35(41):2864-72 5792556 - Am J Pathol. 1969 Jul;56(1):111-28 16531613 - N Engl J Med. 2006 Apr 13;354(15):1567-77 18227386 - Circulation. 2008 Feb 12;117(6):823-31 2407253 - Atherosclerosis. 1990 Feb;81(1):51-60 2011158 - N Engl J Med. 1991 Apr 25;324(17):1149-55 1987384 - J Vasc Surg. 1991 Jan;13(1):128-36 26865327 - Sci Rep. 2016 Feb 11;6:17966 11398138 - Metabolism. 2001 Jun;50(6):640-5 |
References_xml | – volume: 313 start-page: 1325 year: 2015 ident: bib35 article-title: Efficacy of folic acid therapy in primary prevention of stroke among adults with hypertension in China publication-title: JAMA – volume: 374 start-page: 861 year: 2016 end-page: 871 ident: bib1 article-title: Clinical practice. Peripheral artery disease publication-title: N. Engl. J. Med. – volume: 113 start-page: 2623 year: 2006 end-page: 2629 ident: bib24 article-title: Risk factors for progression of peripheral arterial disease in large and small vessels publication-title: Circulation – volume: 467 start-page: 14 year: 2014 end-page: 21 ident: bib31 article-title: Using S-adenosyl-L-homocysteine capture compounds to characterize S-adenosyl-L-methionine and S-adenosyl-L-homocysteine binding proteins publication-title: Anal. Biochem. – volume: 11 start-page: 217 year: 1997 end-page: 223 ident: bib18 article-title: Fasting total plasma homocysteine and atherosclerotic peripheral vascular disease publication-title: Ann. Vasc. Surg. – volume: 25 start-page: 282 year: 1996 end-page: 290 ident: bib3 article-title: The prevalence of asymptomatic and unrecognized peripheral arterial occlusive disease publication-title: Int. J. Epidemiol. – volume: 338 start-page: 1042 year: 1998 end-page: 1050 ident: bib9 article-title: Homocysteine and atherothrombosis publication-title: N. Engl. J. Med. – volume: 38 start-page: 316 year: 2009 end-page: 322 ident: bib17 article-title: Homocysteine and peripheral arterial disease: systematic review and meta-analysis publication-title: Eur. J. Vasc. Endovasc. Surg. – volume: 56 start-page: 111 year: 1969 end-page: 128 ident: bib6 article-title: Vascular pathology of homocysteinemia: implications for the pathogenesis of arteriosclerosis publication-title: Am. J. Pathol. – volume: 59 start-page: 1087 year: 2006 end-page: 1091 ident: bib22 article-title: Review: a gentle introduction to imputation of missing values publication-title: J. Clin. Epidemiol. – volume: 81 start-page: 51 year: 1990 end-page: 60 ident: bib15 article-title: Impaired homocysteine metabolism in early-onset cerebral and peripheral occlusive arterial disease. Effects of pyridoxine and folic acid treatment publication-title: Atherosclerosis – volume: 117 start-page: 823 year: 2008 end-page: 831 ident: bib26 article-title: Symptomatic peripheral arterial disease in women: nontraditional biomarkers of elevated risk publication-title: Circulation – volume: 354 start-page: 1567 year: 2006 end-page: 1577 ident: bib36 article-title: Homocysteine lowering with folic acid and B vitamins in vascular disease publication-title: N. Engl. J. Med. – volume: 96 start-page: 239 year: 1994 end-page: 246 ident: bib11 article-title: Sensitivity of serum methylmalonic acid and total homocysteine determinations for diagnosing cobalamin and folate deficiencies publication-title: Am. J. Med. – volume: 324 start-page: 1149 year: 1991 end-page: 1155 ident: bib14 article-title: Hyperhomocysteinemia: an independent risk factor for vascular disease publication-title: N. Engl. J. Med. – volume: 101 start-page: 875 year: 2012 end-page: 883 ident: bib21 article-title: Automated photoplethysmography-based determination of ankle-brachial index: a validation study against Doppler sonography publication-title: Clin. Res. Cardiol. – volume: 50 start-page: 640 year: 2001 end-page: 645 ident: bib28 article-title: Factors explaining the difference of total homocysteine between men and women in the European Investigation into Cancer and Nutrition Potsdam study publication-title: Metabolism – volume: 114 start-page: 473 year: 1989 end-page: 501 ident: bib7 article-title: Plasma homocysteine, a risk factor for vascular disease: plasma levels in health, disease, and drug therapy publication-title: J. Lab. Clin. Med. – volume: 170 start-page: 1622 year: 2010 end-page: 1631 ident: bib37 article-title: Effects of lowering homocysteine levels with B vitamins on cardiovascular disease, cancer, and cause-specific mortality: meta-analysis of 8 randomized trials involving 37485 individuals publication-title: Arch. Intern Med. – volume: 235 start-page: 94 year: 2014 end-page: 101 ident: bib27 article-title: Plasma homocysteine, dietary B vitamins, betaine, and choline and risk of peripheral artery disease publication-title: Atherosclerosis – volume: 7 start-page: 391 year: 1993 end-page: 396 ident: bib16 article-title: Hyperhomocysteinemia in patients operated for lower extremity ischaemia below the age of 50–effect of smoking and extent of disease publication-title: Eur. J. Vasc. Surg. – volume: 382 start-page: 1329 year: 2013 end-page: 1340 ident: bib2 article-title: Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis publication-title: Lancet – volume: 35 start-page: 2864 year: 2014 end-page: 2872 ident: bib5 article-title: Statin therapy and long-term adverse limb outcomes in patients with peripheral artery disease: insights from the REACH registry publication-title: Eur. Heart J. – volume: 285 start-page: 2481 year: 2001 end-page: 2485 ident: bib23 article-title: Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease publication-title: JAMA – volume: 49 start-page: 711 year: 2009 end-page: 718 ident: bib34 article-title: Peripheral arterial disease and methylenetetrahydrofolate reductase (MTHFR) C677T mutations: a case-control study and meta-analysis publication-title: J. Vasc. Surg. – volume: 2 start-page: 386 year: 1996 end-page: 389 ident: bib8 article-title: Homocysteine and vascular disease publication-title: Nat. Med. – volume: 67 start-page: 232 year: 2008 end-page: 237 ident: bib33 article-title: Homocysteine, B-vitamins and CVD publication-title: Proc. Nutr. Soc. – volume: 12 start-page: 517 year: 2002 end-page: 528 ident: bib30 article-title: Characterization of human soluble high and low activity catechol-O-methyltransferase catalyzed catechol estrogen methylation publication-title: Pharmacogenetics – volume: 274 start-page: 1049 year: 1995 end-page: 1057 ident: bib13 article-title: A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes publication-title: JAMA – volume: 295 start-page: 180 year: 2006 end-page: 189 ident: bib4 article-title: International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis publication-title: JAMA – volume: 8 start-page: 211 year: 2015 end-page: 219 ident: bib32 article-title: Homocysteine and the pathogenesis of atherosclerosis publication-title: Expert Rev. Clin. Pharmacol. – volume: 13 start-page: 128 year: 1991 end-page: 136 ident: bib25 article-title: The association of elevated plasma homocyst(e)ine with progression of symptomatic peripheral arterial disease publication-title: J. Vasc. Surg. – volume: 41 start-page: S72 year: 1993 end-page: S77 ident: bib10 article-title: Hyperhomocysteinemia, a risk factor for atherosclerosis in chronic uremic patients publication-title: Kidney Int. Suppl. – volume: 65 start-page: 1447 year: 2013 end-page: 1454 ident: bib29 article-title: Mass spectrometry evidence for formation of estrogen–homocysteine conjugates: estrogens can regulate homocysteine levels publication-title: Free Radic. Biol. Med. – volume: 126 start-page: 2890 year: 2012 end-page: 2909 ident: bib20 article-title: Measurement and interpretation of the ankle-brachial index: a scientific statement from the American Heart Association publication-title: Circulation – volume: 27 start-page: 517 year: 1996 end-page: 527 ident: bib12 article-title: Homocysteine and coronary atherosclerosis publication-title: J. Am. Coll. Cardiol. – volume: 6 start-page: 17966 year: 2016 ident: bib19 article-title: Hyperhomocysteinaemia is an independent risk factor of abdominal aortic aneurysm in a Chinese Han population publication-title: Sci. Rep. – volume: 114 start-page: 473 issue: 5 year: 1989 ident: 10.1016/j.atherosclerosis.2017.05.006_bib7 article-title: Plasma homocysteine, a risk factor for vascular disease: plasma levels in health, disease, and drug therapy publication-title: J. Lab. Clin. Med. – volume: 354 start-page: 1567 issue: 15 year: 2006 ident: 10.1016/j.atherosclerosis.2017.05.006_bib36 article-title: Homocysteine lowering with folic acid and B vitamins in vascular disease publication-title: N. Engl. J. Med. doi: 10.1056/NEJMoa060900 – volume: 65 start-page: 1447 year: 2013 ident: 10.1016/j.atherosclerosis.2017.05.006_bib29 article-title: Mass spectrometry evidence for formation of estrogen–homocysteine conjugates: estrogens can regulate homocysteine levels publication-title: Free Radic. Biol. Med. doi: 10.1016/j.freeradbiomed.2013.07.041 – volume: 382 start-page: 1329 issue: 9901 year: 2013 ident: 10.1016/j.atherosclerosis.2017.05.006_bib2 article-title: Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis publication-title: Lancet doi: 10.1016/S0140-6736(13)61249-0 – volume: 27 start-page: 517 issue: 3 year: 1996 ident: 10.1016/j.atherosclerosis.2017.05.006_bib12 article-title: Homocysteine and coronary atherosclerosis publication-title: J. Am. Coll. Cardiol. doi: 10.1016/0735-1097(95)00508-0 – volume: 41 start-page: S72 year: 1993 ident: 10.1016/j.atherosclerosis.2017.05.006_bib10 article-title: Hyperhomocysteinemia, a risk factor for atherosclerosis in chronic uremic patients publication-title: Kidney Int. Suppl. – volume: 67 start-page: 232 issue: 2 year: 2008 ident: 10.1016/j.atherosclerosis.2017.05.006_bib33 article-title: Homocysteine, B-vitamins and CVD publication-title: Proc. Nutr. Soc. doi: 10.1017/S0029665108007076 – volume: 7 start-page: 391 issue: 4 year: 1993 ident: 10.1016/j.atherosclerosis.2017.05.006_bib16 article-title: Hyperhomocysteinemia in patients operated for lower extremity ischaemia below the age of 50–effect of smoking and extent of disease publication-title: Eur. J. Vasc. Surg. doi: 10.1016/S0950-821X(05)80255-5 – volume: 313 start-page: 1325 issue: 13 year: 2015 ident: 10.1016/j.atherosclerosis.2017.05.006_bib35 article-title: Efficacy of folic acid therapy in primary prevention of stroke among adults with hypertension in China publication-title: JAMA doi: 10.1001/jama.2015.2274 – volume: 59 start-page: 1087 issue: 10 year: 2006 ident: 10.1016/j.atherosclerosis.2017.05.006_bib22 article-title: Review: a gentle introduction to imputation of missing values publication-title: J. Clin. Epidemiol. doi: 10.1016/j.jclinepi.2006.01.014 – volume: 467 start-page: 14 year: 2014 ident: 10.1016/j.atherosclerosis.2017.05.006_bib31 article-title: Using S-adenosyl-L-homocysteine capture compounds to characterize S-adenosyl-L-methionine and S-adenosyl-L-homocysteine binding proteins publication-title: Anal. Biochem. doi: 10.1016/j.ab.2014.08.013 – volume: 374 start-page: 861 issue: 9 year: 2016 ident: 10.1016/j.atherosclerosis.2017.05.006_bib1 article-title: Clinical practice. Peripheral artery disease publication-title: N. Engl. J. Med. doi: 10.1056/NEJMcp1507631 – volume: 50 start-page: 640 issue: 6 year: 2001 ident: 10.1016/j.atherosclerosis.2017.05.006_bib28 article-title: Factors explaining the difference of total homocysteine between men and women in the European Investigation into Cancer and Nutrition Potsdam study publication-title: Metabolism doi: 10.1053/meta.2001.23286 – volume: 101 start-page: 875 issue: 11 year: 2012 ident: 10.1016/j.atherosclerosis.2017.05.006_bib21 article-title: Automated photoplethysmography-based determination of ankle-brachial index: a validation study against Doppler sonography publication-title: Clin. Res. Cardiol. doi: 10.1007/s00392-012-0471-z – volume: 56 start-page: 111 issue: 1 year: 1969 ident: 10.1016/j.atherosclerosis.2017.05.006_bib6 article-title: Vascular pathology of homocysteinemia: implications for the pathogenesis of arteriosclerosis publication-title: Am. J. Pathol. – volume: 170 start-page: 1622 issue: 18 year: 2010 ident: 10.1016/j.atherosclerosis.2017.05.006_bib37 article-title: Effects of lowering homocysteine levels with B vitamins on cardiovascular disease, cancer, and cause-specific mortality: meta-analysis of 8 randomized trials involving 37485 individuals publication-title: Arch. Intern Med. doi: 10.1001/archinternmed.2010.348 – volume: 49 start-page: 711 issue: 3 year: 2009 ident: 10.1016/j.atherosclerosis.2017.05.006_bib34 article-title: Peripheral arterial disease and methylenetetrahydrofolate reductase (MTHFR) C677T mutations: a case-control study and meta-analysis publication-title: J. Vasc. Surg. doi: 10.1016/j.jvs.2008.10.004 – volume: 285 start-page: 2481 issue: 19 year: 2001 ident: 10.1016/j.atherosclerosis.2017.05.006_bib23 article-title: Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease publication-title: JAMA doi: 10.1001/jama.285.19.2481 – volume: 235 start-page: 94 issue: 1 year: 2014 ident: 10.1016/j.atherosclerosis.2017.05.006_bib27 article-title: Plasma homocysteine, dietary B vitamins, betaine, and choline and risk of peripheral artery disease publication-title: Atherosclerosis doi: 10.1016/j.atherosclerosis.2014.04.010 – volume: 12 start-page: 517 issue: 7 year: 2002 ident: 10.1016/j.atherosclerosis.2017.05.006_bib30 article-title: Characterization of human soluble high and low activity catechol-O-methyltransferase catalyzed catechol estrogen methylation publication-title: Pharmacogenetics doi: 10.1097/00008571-200210000-00003 – volume: 35 start-page: 2864 issue: 41 year: 2014 ident: 10.1016/j.atherosclerosis.2017.05.006_bib5 article-title: Statin therapy and long-term adverse limb outcomes in patients with peripheral artery disease: insights from the REACH registry publication-title: Eur. Heart J. doi: 10.1093/eurheartj/ehu080 – volume: 81 start-page: 51 issue: 1 year: 1990 ident: 10.1016/j.atherosclerosis.2017.05.006_bib15 article-title: Impaired homocysteine metabolism in early-onset cerebral and peripheral occlusive arterial disease. Effects of pyridoxine and folic acid treatment publication-title: Atherosclerosis doi: 10.1016/0021-9150(90)90058-Q – volume: 126 start-page: 2890 issue: 24 year: 2012 ident: 10.1016/j.atherosclerosis.2017.05.006_bib20 article-title: Measurement and interpretation of the ankle-brachial index: a scientific statement from the American Heart Association publication-title: Circulation doi: 10.1161/CIR.0b013e318276fbcb – volume: 38 start-page: 316 issue: 3 year: 2009 ident: 10.1016/j.atherosclerosis.2017.05.006_bib17 article-title: Homocysteine and peripheral arterial disease: systematic review and meta-analysis publication-title: Eur. J. Vasc. Endovasc. Surg. doi: 10.1016/j.ejvs.2009.05.007 – volume: 324 start-page: 1149 issue: 17 year: 1991 ident: 10.1016/j.atherosclerosis.2017.05.006_bib14 article-title: Hyperhomocysteinemia: an independent risk factor for vascular disease publication-title: N. Engl. J. Med. doi: 10.1056/NEJM199104253241701 – volume: 338 start-page: 1042 issue: 15 year: 1998 ident: 10.1016/j.atherosclerosis.2017.05.006_bib9 article-title: Homocysteine and atherothrombosis publication-title: N. Engl. J. Med. doi: 10.1056/NEJM199804093381507 – volume: 8 start-page: 211 issue: 2 year: 2015 ident: 10.1016/j.atherosclerosis.2017.05.006_bib32 article-title: Homocysteine and the pathogenesis of atherosclerosis publication-title: Expert Rev. Clin. Pharmacol. doi: 10.1586/17512433.2015.1010516 – volume: 113 start-page: 2623 issue: 22 year: 2006 ident: 10.1016/j.atherosclerosis.2017.05.006_bib24 article-title: Risk factors for progression of peripheral arterial disease in large and small vessels publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.105.608679 – volume: 117 start-page: 823 issue: 6 year: 2008 ident: 10.1016/j.atherosclerosis.2017.05.006_bib26 article-title: Symptomatic peripheral arterial disease in women: nontraditional biomarkers of elevated risk publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.107.719369 – volume: 6 start-page: 17966 year: 2016 ident: 10.1016/j.atherosclerosis.2017.05.006_bib19 article-title: Hyperhomocysteinaemia is an independent risk factor of abdominal aortic aneurysm in a Chinese Han population publication-title: Sci. Rep. doi: 10.1038/srep17966 – volume: 13 start-page: 128 issue: 1 year: 1991 ident: 10.1016/j.atherosclerosis.2017.05.006_bib25 article-title: The association of elevated plasma homocyst(e)ine with progression of symptomatic peripheral arterial disease publication-title: J. Vasc. Surg. doi: 10.1016/0741-5214(91)90020-U – volume: 96 start-page: 239 issue: 3 year: 1994 ident: 10.1016/j.atherosclerosis.2017.05.006_bib11 article-title: Sensitivity of serum methylmalonic acid and total homocysteine determinations for diagnosing cobalamin and folate deficiencies publication-title: Am. J. Med. doi: 10.1016/0002-9343(94)90149-X – volume: 295 start-page: 180 issue: 2 year: 2006 ident: 10.1016/j.atherosclerosis.2017.05.006_bib4 article-title: International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis publication-title: JAMA doi: 10.1001/jama.295.2.180 – volume: 11 start-page: 217 issue: 3 year: 1997 ident: 10.1016/j.atherosclerosis.2017.05.006_bib18 article-title: Fasting total plasma homocysteine and atherosclerotic peripheral vascular disease publication-title: Ann. Vasc. Surg. doi: 10.1007/s100169900037 – volume: 25 start-page: 282 issue: 2 year: 1996 ident: 10.1016/j.atherosclerosis.2017.05.006_bib3 article-title: The prevalence of asymptomatic and unrecognized peripheral arterial occlusive disease publication-title: Int. J. Epidemiol. doi: 10.1093/ije/25.2.282 – volume: 2 start-page: 386 issue: 4 year: 1996 ident: 10.1016/j.atherosclerosis.2017.05.006_bib8 article-title: Homocysteine and vascular disease publication-title: Nat. Med. doi: 10.1038/nm0496-386 – volume: 274 start-page: 1049 issue: 13 year: 1995 ident: 10.1016/j.atherosclerosis.2017.05.006_bib13 article-title: A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes publication-title: JAMA doi: 10.1001/jama.1995.03530130055028 – reference: 23928335 - Free Radic Biol Med. 2013 Dec;65:1447-54 – reference: 8606260 - J Am Coll Cardiol. 1996 Mar 1;27(3):517-27 – reference: 7563456 - JAMA. 1995 Oct 4;274(13):1049-57 – reference: 26865327 - Sci Rep. 2016 Feb 11;6:17966 – reference: 8154512 - Am J Med. 1994 Mar;96(3):239-46 – reference: 2681479 - J Lab Clin Med. 1989 Nov;114(5):473-501 – reference: 5792556 - Am J Pathol. 1969 Jul;56(1):111-28 – reference: 2011158 - N Engl J Med. 1991 Apr 25;324(17):1149-55 – reference: 8320950 - Kidney Int Suppl. 1993 Jun;41:S72-7 – reference: 11368701 - JAMA. 2001 May 16;285(19):2481-5 – reference: 25172130 - Anal Biochem. 2014 Dec 15;467:14-21 – reference: 16980149 - J Clin Epidemiol. 2006 Oct;59(10):1087-91 – reference: 23915883 - Lancet. 2013 Oct 19;382(9901):1329-40 – reference: 1987384 - J Vasc Surg. 1991 Jan;13(1):128-36 – reference: 24819748 - Atherosclerosis. 2014 Jul;235(1):94-101 – reference: 9535670 - N Engl J Med. 1998 Apr 9;338(15):1042-50 – reference: 8597939 - Nat Med. 1996 Apr;2(4):386-9 – reference: 9140594 - Ann Vasc Surg. 1997 May;11(3):217-23 – reference: 16735675 - Circulation. 2006 Jun 6;113(22):2623-9 – reference: 23159553 - Circulation. 2012 Dec 11;126(24):2890-909 – reference: 24585266 - Eur Heart J. 2014 Nov 1;35(41):2864-72 – reference: 19560951 - Eur J Vasc Endovasc Surg. 2009 Sep;38(3):316-22 – reference: 16531613 - N Engl J Med. 2006 Apr 13;354(15):1567-77 – reference: 20937919 - Arch Intern Med. 2010 Oct 11;170(18):1622-31 – reference: 18227386 - Circulation. 2008 Feb 12;117(6):823-31 – reference: 18412997 - Proc Nutr Soc. 2008 May;67(2):232-7 – reference: 25771069 - JAMA. 2015 Apr 7;313(13):1325-35 – reference: 16403930 - JAMA. 2006 Jan 11;295(2):180-9 – reference: 9119553 - Int J Epidemiol. 1996 Apr;25(2):282-90 – reference: 22584382 - Clin Res Cardiol. 2012 Nov;101(11):875-83 – reference: 19157768 - J Vasc Surg. 2009 Mar;49(3):711-8 – reference: 8359294 - Eur J Vasc Surg. 1993 Jul;7(4):391-6 – reference: 12360102 - Pharmacogenetics. 2002 Oct;12(7):517-28 – reference: 2407253 - Atherosclerosis. 1990 Feb;81(1):51-60 – reference: 11398138 - Metabolism. 2001 Jun;50(6):640-5 – reference: 26962905 - N Engl J Med. 2016 Mar 3;374(9):861-71 |
SSID | ssj0004718 |
Score | 2.347264 |
Snippet | Hyperhomocysteineamia (HHcy) has long been suggested as a risk factor for atherosclerosis. However, the association between HHcy and peripheral arterial... Abstract Background and aims Hyperhomocysteineamia (HHcy) has long been suggested as a risk factor for atherosclerosis. However, the association between HHcy... |
SourceID | pubmedcentral proquest pubmed crossref elsevier |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 205 |
SubjectTerms | Aged Ankle Brachial Index Asian Continental Ancestry Group Biomarkers - blood Cardiovascular Case-Control Studies Case-control study Chi-Square Distribution China - epidemiology Female Homocysteine Homocysteine - blood Humans Hyperhomocysteineamia Hyperhomocysteinemia - blood Hyperhomocysteinemia - diagnosis Hyperhomocysteinemia - ethnology Logistic Models Male Middle Aged Multivariate Analysis Odds Ratio Peripheral arterial disease Peripheral Arterial Disease - diagnosis Peripheral Arterial Disease - ethnology Prevalence Risk Assessment Risk Factors |
Title | Hyperhomocysteinaemia is an independent risk factor for peripheral arterial disease in a Chinese Han population |
URI | https://www.clinicalkey.com/#!/content/1-s2.0-S0021915017301958 https://www.clinicalkey.es/playcontent/1-s2.0-S0021915017301958 https://dx.doi.org/10.1016/j.atherosclerosis.2017.05.006 https://www.ncbi.nlm.nih.gov/pubmed/28651188 https://www.proquest.com/docview/1914286828 https://pubmed.ncbi.nlm.nih.gov/PMC5557685 |
Volume | 263 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
journalDatabaseRights | – providerCode: PRVESC databaseName: Baden-Württemberg Complete Freedom Collection (Elsevier) customDbUrl: eissn: 1879-1484 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0004718 issn: 0021-9150 databaseCode: GBLVA dateStart: 20110101 isFulltext: true titleUrlDefault: https://www.sciencedirect.com providerName: Elsevier – providerCode: PRVESC databaseName: Elsevier Freedom Collection customDbUrl: eissn: 1879-1484 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0004718 issn: 0021-9150 databaseCode: ACRLP dateStart: 19950106 isFulltext: true titleUrlDefault: https://www.sciencedirect.com providerName: Elsevier – providerCode: PRVESC databaseName: Elsevier ScienceDirect Freedom Collection Journals customDbUrl: eissn: 1879-1484 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0004718 issn: 0021-9150 databaseCode: AIKHN dateStart: 19950106 isFulltext: true titleUrlDefault: https://www.sciencedirect.com providerName: Elsevier – providerCode: PRVESC databaseName: Elsevier SD Freedom Collection customDbUrl: eissn: 1879-1484 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0004718 issn: 0021-9150 databaseCode: .~1 dateStart: 19950101 isFulltext: true titleUrlDefault: https://www.sciencedirect.com providerName: Elsevier – providerCode: PRVLSH databaseName: Elsevier Journals customDbUrl: mediaType: online eissn: 1879-1484 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0004718 issn: 0021-9150 databaseCode: AKRWK dateStart: 19700101 isFulltext: true providerName: Library Specific Holdings |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3dS90wFD-IA9nLmPu800kG22NnP9KkARkTmVRFnyb4FtI0xYq2F3t99W_3nDatu-qDw5dCmo-W5OTkd8g5vwPw3SKKQKsCLVVexQFPQxtkltsgrkTlhDKc9xftxyciP-WHZ-nZCuyNsTDkVul1_6DTe23t32z72dye1zXF-OJuQzwTkZCqlAJ-if0LZfrn7b2bBynfwc0jCqj1Gvy49_HqQVbb4ZD4rIm9OxqIPCkB0tPn1GMc-tCd8p_zaf8tvPHAku0O_74OK655B2vH_ur8PbQ5WpzX5-1Va4m8uW6Mu6oNqztmGlZPyXAXjJzN2ZCGhyGiZUSF3HMPXLLe_xMFlvlrHezHDKMU3A4LOQ40n_KBfYDT_T9_9_LAZ1sIrIjEIpCmVCUvIiu45GWUWVkUnBfKJjzkTjhlTJUllSqMwroEgZIzSZXFrqSDsOTJR1ht2sZ9BmZw1kUiI4dgkMcSjbKsMFzi27BKjFQz2BnnVltPRU4ZMS716HN2oR8sjaal0WGqcWlmIKbu84GT47kdf40LqcfAU1SVGk-P5w4gnxrAdX7jdzrSXaxD_Ug4Z_B76rkk3__z8W-j7GnUAXSxYxrX3uBHFfHmCTSeZ_BpkMVpYijyGI1IrJFLUjo1IH7x5ZqmPu95xtOUjNH0y8t_fQNeU2lwnNyE1cX1jfuKYG5RbPW7dQte7R4c5Sd3Y0RQHg |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LT9wwEB7RRaK9IPpeCq0rtceIPBw7kaqqCBWFwu4JJG6W4zgiCJIVWf5_ZxIndIEDqJdIiTNOZI_H38gz3wB8M4gi0KtAT5WXocdj33iJ4cYLS1FakWrOu4P22VxkZ_zPeXy-BgdDLgyFVTrb39v0zlq7J3tuNPcWVUU5vrjaEM8EpKRpnLyAdR6jTZ7A-v7RcTa_S4-UQW-QKRoBBTbg-12YV4ezmhZ7xWtFBN5Bz-VJNZAe36oeQtH7EZX_bFGHW7DpsCXb73__NazZ-g1szNzp-VtoMnQ6by6a68YQf3NVa3tdaVa1TNesGuvhLhnFm7O-Eg9DUMuIDbmjH7hiXQgo6ixzJzsoxzSjKtwWbzLsaDGWBHsHZ4e_Tw8yzxVc8IwIxNKTukgLngdGcMmLIDEyzznPUxNxn1thU63LJCrTXKfYFiFWsjoqk9AWtBcWPHoPk7qp7UdgGkddRDKwiAd5KNEvS3LNJT71y0jLdAo_hrFVxrGRU1GMKzWEnV2qe1OjaGqUHyucmimIUXzR03I8VfDnMJFqyD1Fa6lwA3lqB_KxDmzr1n6rAtWGylcP9HMKv0bJFRV_zse_Drqn0AzQ2Y6ubXOLH02JOk-g_zyFD70ujgNDycfoR2KLXNHS8QWiGF9tqauLjmo8jskfjbf__9e_wMvsdHaiTo7mx5_gFbX0cZQ7MFne3NpdxHbL_LNbu38BlKBSyQ |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Hyperhomocysteinaemia+is+an+independent+risk+factor+for+peripheral+arterial+disease+in+a+Chinese+Han+population&rft.jtitle=Atherosclerosis&rft.au=Rong%2C+Dan&rft.au=Liu%2C+Jie&rft.au=Jia%2C+Xin&rft.au=AL-Nafisee%2C+Daniah&rft.date=2017-08-01&rft.issn=0021-9150&rft.eissn=1879-1484&rft.volume=263&rft.spage=205&rft.epage=210&rft_id=info:doi/10.1016%2Fj.atherosclerosis.2017.05.006&rft_id=info%3Apmid%2F28651188&rft.externalDocID=PMC5557685 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0021-9150&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0021-9150&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0021-9150&client=summon |